Gemcitabine-mediated apoptosis is associated with increased CD95 surface expression but is not inhibited by DN-FADD in Colo357 pancreatic cancer cells

Cancer Letters

Volumn 227, Issue 2, 2005, Pages 193-200

  Christgen, Matthias ^a   Schniewind, Bodo ^a   Jueschke, Astrid ^a   Ungefroren, Hendrik ^a   Kalthoff, Holger ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Caspase 8; CD95 FAS Apo 1; FADD; Gemcitabine; Pancreatic Cancer

Indexed keywords

CASPASE 8; CYTOCHROME C; FAS ANTIBODY; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GEMCITABINE; MUTANT PROTEIN;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS; CELL SURFACE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME KINETICS; HUMAN; HUMAN CELL; NUCLEAR IMPORT; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD95; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, WESTERN; CASPASE 8; CASPASES; DEOXYCYTIDINE; ENZYME ACTIVATION; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FLOW CYTOMETRY; GENES, DOMINANT; HUMANS; PANCREATIC NEOPLASMS; RETROVIRIDAE; RIBONUCLEOTIDE REDUCTASES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 23844505067     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.01.016     Document Type: Article

References (21)

1. J. Carmichael, U. Fink, R.C. Russell, M.F. Spittle, A. Harris, and G. Spiessi Phase II study of gemcitabine in patients with advanced pancreatic cancer Br. J. Cancer 73 1996 101 105
2. M.E. Peter, and P.H. Krammer The CD95(Apo-1/FAS) DISC and beyond Cell Death Differ. 10 2003 26 35
3. A.M. Chinnaiyan, C.G. Tepper, F. Seldin, K. O'Rourke, F.C. Kischkel, and S. Hellbardt FADD/MORT1 Is a common mediator of CD95 (FAS/Apo-1) and tumor necrosis factor receptor-induced apoptosis J. Biol. Chem. 271 1996 4961 4965
4. M.P. Boldin, T.M. Goncharov, Y.V. Goltsev, and D. Wallach Involvement of MACH, a novel MORT1/FADD-interacting protease, in FAS/APO-1- and TNF receptor-induced cell death Cell 85 1998 803 815
5. C.G. Ferreira, S.W. Span, G.J. Peters, F.A. Kruyt, and G. Giaccone Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460 Cancer Res. 60 2000 7133 7141
6. E. Bandala, M. Espinosa, V. Maldonado, and J. Melendez-Zajgla Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine Biochem. Pharmacol. 62 2001 13 19
7. C.E. Chalfant, K. Rathman, R.L. Pinkerman, R.E. Wood, L.M. Obeid, and B. Ogretmen De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells dependence on protein phosphatase-1 J. Biol. Chem. 277 2002 12587 12595
8. A. Trauzold, S. Schmiedel, C. Röder, C. Tams, M. Christgen, and S. Oestern Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells Br. J. Cancer 89 2003 1714 1721
9. B.D. Howard, L. Boenicke, B. Schniewind, D. Henne-Bruns, and H. Kalthoff Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir Cancer Gene Ther. 7 2000 927 938
10. B. Schniewind, M. Christgen, R. Kurdow, S. Haye, B. Kremer, and H. Kalthoff Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria mediated apoptosis Int. J. Cancer 109 2004 182 189
11. C. Scaffidi, S. Fulda, A. Srinivasan, C. Friesen, F. Li, and K.J. Tomaselli Two CD95(Apo-1/Fas) signaling pathways Eur. Mol. Biol. J. 17 1998 1675 1687
12. C.G. Ferreira, C. Tolis, S.W. Span, G.J. Peters, T. van Lopik, and A.J. Kummer Drug-induced apoptosis in lung cancer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway Clin. Cancer Res. 6 2000 203 212
13. H. Ungefroren, M. Voss, M. Jansen, C. Roeder, D. Henne-Bruns, and B. Kremer Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis Cancer Res. 58 1998 1741 1749
14. S.M. Ibrahim, J. Ringel, C. Schmidt, B. Ringel, P. Müller, and D. Koczan Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death Pancreas 23 2001 72 79
15. M. Gomez-Angelats, and J.A. Cidlowski Molecular evidence for the nuclear localization of FADD Cell Death Differ. 10 2003 791 797
16. G.C. Chang, S.L. Hsu, J.R. Tsai, W.J. Wu, C.Y. Chen, and G.T. Sheu Extracellular signal-regulated kinase activation and Bcl-2 downregulation mediate apoptosis after gemcitabine treatment partly via a p53-independent pathway Eur. J. Pharmacol. 2004 502169 502183
17. D.R. Jones, R.M. Broad, L.D. Comeau, S.J. Parsons, and M.W. Mayo Inhibition of nuclear factor kappaB chemosensitizes non-small cell lung cancer through cytochrome c release and caspase activation J. Thorac. Cardiovasc. Surg. 123 2002 310 317
18. K. Kitamura, Y. Minami, K. Yamamoto, Y. Akao, H. Kiyoi, and H. Saito Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis Leukemia 14 2000 1743 1750
19. C. Belka, P. Marini, A. Lepple-Wienhues, W. Budach, A. Jekle, and M. Los The tyrosine kinase lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation Oncogene 18 1999 4983 4992
20. R.A. Screaton, S. Kiessling, O.J. Sansom, C.B. Millar, K. Maddison, and A. Bird Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: a potential link between genome surveillance and apoptosis Proc. Natl Acad. Sci. 100 2003 5211 5216
21. A.H. Stegh, O. Schickling, A. Ehret, C. Scaffidi, C. Peterhaensel, and T.G. Hofmann DEDD, a novel death effector domain-containing protein, targeted to the nucleous Eur. Mol. Biol. Org. J. 17 1998 5974 5986